⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

AI Visibility Scorecard

US FDA has removed REMS requirement for TRYVIO (aprocitentan) - The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™ are no longer necessary to ensure the benefits of the drug outweigh the risk of embryo-fetal toxicity. Prescribers and pharmacies are no longer required to interact with the REMS.

Name: US FDA has removed REMS requirement for TRYVIO (aprocitentan) - The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™ are no longer necessary to ensure the benefits of the drug outweigh the risk of embryo-fetal toxicity. Prescribers and pharmacies are no longer required to interact with the REMS. - AI Visibility Score
Creator: Engagemii
Published: 2026-08-01T22:39:07.542Z
License: https://creativecommons.org/licenses/by/4.0/

Unclaimed

tryviorems.com · Food & Beverage

At 1.1/10, US FDA has removed REMS requirement for TRYVIO (aprocitentan) - The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™ are no longer necessary to ensure the benefits of the drug outweigh the risk of embryo-fetal toxicity. Prescribers and pharmacies are no longer required to interact with the REMS. is close to invisible in AI search today. Most assistants will not cite it when asked about your category - fixable, and the signals below show exactly where to start.

Claim this page free See the breakdown

Monitoring for AI engine activity

In the Engagemii AEO index

#1,701,974 of 1,703,529 in Food & Beverage for AI visibility

1.1

/10

AEO Score

About US FDA has removed REMS requirement for TRYVIO (aprocitentan) - The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™ are no longer necessary to ensure the benefits of the drug outweigh the risk of embryo-fetal toxicity. Prescribers and pharmacies are no longer required to interact with the REMS.

from our crawl and measurement

"The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™." That is how US FDA has removed REMS requirement for TRYVIO (aprocitentan) introduces itself. To AI engines like ChatGPT and Perplexity it is close to invisible, scoring 1.1 out of 10.

On the page it is passable on a partly stated business identity and basic crawler access. What holds it back is a heading structure that lays out what it offers, structured data describing the business, credibility markers like credentials or reviews and sitemaps and entity links AI can follow.

Industry · Food & Beverage

Last scored · Aug 1, 2026

The 6 signals AI reads

Higher is better · 0-10

Structured Data

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

Clear headings and answer-style content.

Entity Clarity

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

Experience, Expertise, Authority, Trust markers.

Technical AEO

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

Sitemaps and entity links AI can follow.

Off-page authority

How the web signals your brand to AI

Backlinks

No inbound links found yet.

Domain Trust

Little domain authority yet.

Entity Presence

Not in AI knowledge graphs yet.

News Mentions

No press coverage found yet.

Community

No community discussion yet.

No Reddit mentions found yet.

What this score means

Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 1.1/10, US FDA has removed REMS requirement for TRYVIO (aprocitentan) - The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™ are no longer necessary to ensure the benefits of the drug outweigh the risk of embryo-fetal toxicity. Prescribers and pharmacies are no longer required to interact with the REMS. is crawlable but under-signaled - fixable, and the signals above are where to start.

Is this your brand?

✓

The exact fixes for US FDA has removed REMS requirement for TRYVIO (aprocitentan) - The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™ are no longer necessary to ensure the benefits of the drug outweigh the risk of embryo-fetal toxicity. Prescribers and pharmacies are no longer required to interact with the REMS.

✓

Which AI engines already crawl you

✓

Weekly ChatGPT & Claude citation tracking

Password (8+ characters)

Already have an account? Sign in

From the blog

Which AI is actually reading your website?→Why your brand doesn't show up in ChatGPT answers→The complete AEO checklist for small business→What is AEO? The beginner's guide→See all posts→

Picked for US FDA has removed REMS requirement for TRYVIO (aprocitentan) - The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™ are no longer necessary to ensure the benefits of the drug outweigh the risk of embryo-fetal toxicity. Prescribers and pharmacies are no longer required to interact with the REMS. : Food & Beverage

Your Ingredient Label Has a Story. Is Anyone Telling It?

Food is the most intimate purchase a person makes. You're deciding what goes into your body, what you feed your family, what aligns with your values. That decision deserves more than a label and a hope.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for US FDA has removed REMS requirement for TRYVIO (aprocitentan) - The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™ are no longer necessary to ensure the benefits of the drug outweigh the risk of embryo-fetal toxicity. Prescribers and pharmacies are no longer required to interact with the REMS. .

Source & Attribution

Scored by Engagemii on August 1, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/tryviorems

Cite this score: Engagemii (2026). "AEO Score for US FDA has removed REMS requirement for TRYVIO (aprocitentan) - The U.S. Food and Drug Administration (FDA) has determined the approved Risk Evaluation and Mitigation Strategies (REMS) for TRYVIO ™ are no longer necessary to ensure the benefits of the drug outweigh the risk of embryo-fetal toxicity. Prescribers and pharmacies are no longer required to interact with the REMS. ." Retrieved from https://engagemii.com/aeo/brands/tryviorems

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.